Multiplex Assay Kit for E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay)

CDHE; CD324; CDH1; Arc1; ECAD; CDH-E; E-CAD; LCAM; UVO; Cadherin 1 Type 1; Uvomorulin; E-Cadherin; Calcium-Dependent Adhesion Protein, Epithelial; Liver Cell Adhesion Molecule

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-93 87
EDTA plasma(n=5) 85-97 92
heparin plasma(n=5) 96-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-99% 78-99% 95-102% 79-104%
EDTA plasma(n=5) 80-97% 96-105% 81-98% 88-102%
heparin plasma(n=5) 80-97% 99-105% 79-95% 87-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J Periodontal Res. Novel method for proliferation of oral keratinocyte stem cells Pubmed: 24329011
The Journal of Gene Medicine Modulation of the Dual‐Faced Effects of miR‐141 with Chitosan/miR‐141 Nanoplexes in Breast Cancer Cells Pubmed: 31389101
Cell Adhesion & Migration BST2 regulates interferon gamma-dependent decrease in invasion of HTR-8/SVneo cells via STAT1 and AKT signaling pathways and expression of E-cadherin Pubmed: 31957537
DOKLADY BIOCHEMISTRY AND BIOPHYSICS Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy … Pubmed: 32342301
Non-POU Domain-Containing Octamer-Binding (NONO) Protein Stability Regulated by PIN1 is Crucial for Breast Cancer Tumorigenicity Via the MAPK/β …
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APA017Hu62 Active E-cadherin Cell culture; Activity Assays.
RPA017Hu01 Recombinant E-cadherin Positive Control; Immunogen; SDS-PAGE; WB.
APA017Hu61 Active E-cadherin Cell culture; Activity Assays.
EPA017Hu62 Eukaryotic E-cadherin Positive Control; Immunogen; SDS-PAGE; WB.
EPA017Hu61 Eukaryotic E-cadherin Positive Control; Immunogen; SDS-PAGE; WB.
PAA017Hu01 Polyclonal Antibody to E-cadherin WB; IHC; ICC; IP.
PAA017Hu02 Polyclonal Antibody to E-cadherin WB; IHC; ICC; IP.
LAA017Hu71 Biotin-Linked Polyclonal Antibody to E-cadherin WB; IHC; ICC.
LAA017Hu81 FITC-Linked Polyclonal Antibody to E-cadherin WB; IHC; ICC; IF.
MAA017Hu23 Monoclonal Antibody to E-cadherin WB; IHC; ICC; IP.
MAA017Hu22 Monoclonal Antibody to E-cadherin WB; IHC; ICC; IP.
MAA017Hu21 Monoclonal Antibody to E-cadherin WB; IHC; ICC; IP.
MAA017Hu24 Monoclonal Antibody to E-cadherin WB; IHC; ICC; IP.
SEA017Hu ELISA Kit for E-cadherin Enzyme-linked immunosorbent assay for Antigen Detection.
SCA017Hu CLIA Kit for E-cadherin Chemiluminescent immunoassay for Antigen Detection.
LMA017Hu Multiplex Assay Kit for E-cadherin ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.